Mesoblast Ltd Files 6-K with SEC
Ticker: MEOBF · Form: 6-K · Filed: Dec 4, 2024 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Dec 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, regulatory-update
Related Tickers: MESO
TL;DR
MESO filed a 6-K, basically a heads-up to the SEC about an ASX announcement. No new financials.
AI Summary
On December 3, 2024, Mesoblast Limited filed a new release announcement with the Australian Securities Exchange. This report is being furnished to the SEC as part of their ongoing reporting obligations. The filing does not contain specific financial figures or operational updates beyond the announcement itself.
Why It Matters
This filing indicates Mesoblast Limited is complying with its reporting requirements to the SEC by submitting a recent announcement made to the Australian Securities Exchange.
Risk Assessment
Risk Level: low — This filing is a routine submission of a previously issued press release and does not contain new material financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- Australian Securities Exchange (company) — Exchange where announcement was filed
- December 3, 2024 (date) — Date of announcement filing
FAQ
What is the primary purpose of this 6-K filing?
The primary purpose is to furnish a new release announcement filed by Mesoblast Limited with the Australian Securities Exchange on December 3, 2024, to the U.S. Securities and Exchange Commission.
What specific new information is contained within this 6-K filing?
This 6-K filing itself does not contain new information beyond incorporating by reference the new release announcement filed with the Australian Securities Exchange.
When was the announcement referenced in the filing made public?
The announcement was filed with the Australian Securities Exchange on December 3, 2024.
Who is identified as the Chief Executive Officer and Executive Director of Mesoblast Limited?
Silviu Itescu is identified as the Chief Executive Officer and Executive Director of Mesoblast Limited.
Under which SEC form does Mesoblast Limited typically file its annual reports?
Mesoblast Limited indicates it files annual reports under cover of Form 20-F.
Filing Stats: 212 words · 1 min read · ~1 pages · Grade level 17.3 · Accepted 2024-12-03 17:56:29
Filing Documents
- a2024-12x04rexlemestrocelx.htm (6-K) — 20KB
- exhibit991.htm (EX-99.1) — 13KB
- exhibit991001.jpg (GRAPHIC) — 262KB
- exhibit991002.jpg (GRAPHIC) — 300KB
- exhibit991003.jpg (GRAPHIC) — 245KB
- 0001345099-24-000081.txt ( ) — 1147KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized. Mesoblast Limited s Paul Hughes Paul Hughes Company Secretary Dated December 4, 2024 INDEX TO EXHIBITS Item 99.1 Press release of Mesoblast Ltd, dated December 3, 2024.